Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [11] Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment
    Weir, Matthew R.
    POSTGRADUATE MEDICINE, 2019, : 367 - 375
  • [12] Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes
    Sheng-Kai Ma, Kevin
    Tsai, Serena Yun-Chen
    Holt, Allison
    Chen, Steven T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : 934 - 936
  • [13] EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES
    Sharma, Abhishek
    Kamran, Haroon
    Goel, Sunny
    Mukherjee, Debabrata
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 734 - 735
  • [14] EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES
    Sharma, A.
    Kamran, H.
    Goel, S.
    Mukherjee, D.
    CARDIOLOGY, 2017, 137 : 92 - 92
  • [15] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [16] Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2022, 18 (02): : 198 - 199
  • [17] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [18] Comparative safety of sodium-glucose cotransporter-2 (SGLT-2) inhibitors: Risk of hospitalization and cardiovascular events in patients with type 2 diabetes
    Mansour, Omar
    Chang, Hsien-Yen
    Alexander, G. Caleb
    Singh, Sonal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 52 - 52
  • [19] Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
    Peacock, Sharon C.
    Lovshin, Julie A.
    Cherney, David Z. I.
    ANESTHESIA AND ANALGESIA, 2018, 126 (02): : 699 - 704
  • [20] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Handelsman, Yehuda
    ADVANCES IN THERAPY, 2019, 36 (10) : 2567 - 2586
12345